long-term outcomes of primary obesity surgery endoluminal 2.0: a five-year follow-up

long-term outcomes of primary obesity surgery endoluminal 2.0: a five-year follow-up - POTENTIAL

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON57384

Enrollment

Registered

2024-12-23

Start date

2025-10-27

Completion date

Unknown

Last updated

2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adipositas Overweight

Interventions

POSE 2

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients who underwent a POSE-2 procedure - Patient is >18 years old - The patient is capable of understanding, reading, and signing the informed consent.

Exclusion criteria

Exclusion criteria: - Death - Psychiatric Disorders - Substance abuse - Malignancy - Women who are currently pregnant or within 6 months postpartum at the time of the 5-year follow-up. - Allergic reaction to oral barium contrast

Design outcomes

Primary

Measure	Time frame
Primarily, the percentage of total weight loss (%TWL) at a 5-year follow-up	—

Secondary

Measure	Time frame
secondary the long-term durability and safety of the POSE-2 assessed by gastroscopy and barium swallow. Tertiary the quality of life and overall patient satisfaction, assessed by questionnaires	—

Countries

Netherlands

Contacts

Public ContactGHJM Verkoulen

Zuyderland

bwo@zuyderland.nl088 459 7777

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 14, 2026